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http://dx.doi.org/10.1016/j.kjms.201Abstract Although morphological and anatomical studies indicate that varicose veins are char-
acterizedby venouswallweakening and subendothelial fibrosis, theexact underlying biochemical
mechanismof their development remainsunknown.Additionally, noquantitative proteomic study
of venous proteins leading to decreased contractility of varicose veins has been reported to date.
Therefore, to elucidate themolecularmechanismof altered vascular contractility, this study per-
formed shotgun proteomic analysis to obtain protein expression profiles in patients with varicose
veins. Stable isotopedimethyl labelingcoupledwithnanoLC-MS/MS revealeddownregulation in12
polypeptides, includingmyosin light chain kinase, creatine kinase B-type, ATP synthase, phospho-
glycerate kinase, andpyruvate kinase. However, analyses of protein species associatedwith cyto-
skeletal assembly or with cellular morphology showed no clear up- or down-regulation. These
results indicate that defects in ATP generation and utilization may account for the dysfunctionPlastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, 100 Shih-Chuan 1st
w (S.-D. Lin).
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Quantitative proteomics analysis of varicose veins 595of vascular smoothmuscle following formation of varicose veins. Collectively, the severity of vari-
cose veins depends on the regulatory roles of various protein factors in themetabolic coordination
of physiological functions. This pilot study improves understandingof thepathogenesis of varicose
veins and lays the foundation for further validation and clinical translation of biomarkers for tar-
geted therapies in treating this disease.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The most common sites of varicose veins are the lower limbs
throughout the long saphenous vein and its tributaries [1]. The
exact causes of varicose veins areunknown, but factors known
to affect the prevalence and incidence of varicose veins
include genetic factors, gender, and diet. The disease has also
been associated with insufficient physical activity, obesity,
occupational activity involving long periods of standing, and
advanced age [2e7]. Varicose veins, which are the most
commonmanifestation of chronic venous diseases, affect 25%
ofwomenand 15% ofmen. Up to 80% of the general population
has spider veins [8]. An endoscopic-assisted technique for
managing primary varicose veins developed by Lin et al. has
proven effective for visualizing and clearly identifying char-
acteristic features of varicosities, including supernumerary
tributaries, saccular or lateral bulging deformities of vein
walls, poor contractility, dilation and tortuous changes in
varicose veins, and varicosity of the main channel, its tribu-
taries, and the incompetent perforating veins [1,9,10].
Conservative approaches to reducing the pain and edema
associated with varicose veins include compression stockings
and oral venotonic medication. Endovenous therapies,
including endovenous laser therapy, radiofrequency ablation,
and endovenous foam sclerotherapy, have shown low compli-
cation rates [8,11e13]. Another hypothesized contributor to
the development of varicose veins is cellular aberrations
caused by disturbance of the muscle cell/collagen/elastic
fiber balance with an unknown genetic defect that causes loss
of contractility [14]. Histological studies also show that
structural remodeling characterized by accumulations of
collagen, proteoglycans, and elastic fibers in smooth muscle
cells may decrease venal elasticity while concomitantly
increasing inflammation and thrombus [15e17]. Therefore, in
smooth muscle cells, dysfunction caused by the cytoskeleton,
extracellularmatrices or protein factorsmay be at least partly
to explain thepartial or total loss of contractile force observed
in varicose veins. Although the morphological and pathogenic
mechanism(s) underlying the above abnormalities associated
with varicose veins have been studied intensively, no quanti-
tativestudyhasanalyzedproteomicprofilesofvenousproteins
to elucidate the biochemical development of varicose veins.
Emerging technologies forproteomicanalysishave recently
made analyzing and identifying complex protein mixtures in
biological tissues less tedious and more amenable to routine
analysis [18,19]. Although biological research tends to
emphasize comprehensive global analysis of cellular systems,
reliable and high-throughput analyses of proteome-wide
analysis of proteins were not possible until the advent of
modern proteomics instrumentation. Proteomic metho-dologies for molecular and cellular studies of proteins are
rapidly evolvingandnowprovideafirmbasis for understanding
the complex proteome profiles of total protein mixtures from
whole tissues or cells from various sources [20].
To elucidate the pathogenesis of altered vascular
contractility, this studyperformedgel-free shotgunproteomic
analysis [18,19] coupled with stable isotope dimethyl labeling
[18,19,21] and nanoLC-MS/MS [21e23] to characterize and
comparetheproteinsexpressed invaricoseveinsand innearby
portions of normal tissues in the same veins. The quantitative
proteomic analysis of differential protein expression levels of
normal versus varicose veins revealed at least 455 protein
species with high confidence levels. Of these, 12 proteins,
which included ATP-generating, ATP-utilizing, and glycolytic
enzymes, revealed significant downregulation between
normal and diseased tissues. We hypothesized that, as the
development of varicose veins progresses, systematic de-
creases in these enzymes may cause vascular smooth muscle
dysfunctions leading to morphological aberrations.
Collectively, varicose veins involve various protein fac-
tors with regulatory roles in the metabolic coordination of
physiological functions. To our knowledge, this study is the
first to describe the pathogenesis of varicose vein formation
at the translational level of expressed protein molecules.
This pilot study provides data needed for further validation
and clinical application of identified biomarkers in targeted
therapies for treating varicose veins or arteries.Materials and methods
Chemicals and reagents
Quantitative reagent for protein contents was purchased from
Bio-Rad (Hercules, CA, USA). Trichloroacetic acid (TCA), tri-
fluoroacetic acid (TFA), dithiothreitol, iodoacetamide (IAM),
ethylenediaminetetraacetic acid (EDTA), sodium deoxy-
cholate, sodiumfluoride, formaldehyde-H2, formaldehyde-D2,
ammonium bicarbonate (NH4HCO3), and Triton X-100 were
purchased fromSigmaAldrich (St Louis, MO, USA). Acetonitrile
(ACN) and sodium phosphate were obtained from Merck
(Darmstadt, Germany). Formic acid (FA), sodium acetate, so-
dium cyanoborohydride and sodium chloride (NaCl) were
purchased from Riedel-de Haven (Seelze, Germany). Protease
inhibitors (Complete Mini) were purchased from Roche (Man-
nheim,Germany). Sodiumdodecyl sulfate (SDS) and ureawere
purchased from Amresco (Solon, OH). Modified sequencing-
grade trypsin for in-gel digestion was purchased from Prom-
ega (Madison, WI, USA). Water was deionized to 18 MU by a
Milli-Q system (Millipore, Bedford, MA, USA).
596 C.-J. Kuo et al.Sample collection
All procedures used in this study were approved by the
clinical research ethics committee at Kaohsiung Medical
University Hospital. Varicose vein tissue and segmental
parts of normal vein samples adjacent to varicose veins as
control were obtained from four limbs of four patients who
underwent the endoscopic-assisted removal of the varicose
veins.
Normal or varicose vein tissue specimens (1 g) were
homogenized with a Polytron homogenizer in 1.5 mL
extraction buffer containing 10 mM Tris-HCl pH 7.4, 10 mM
sodium phosphate, 150 mM NaCl, 0.1% SDS, 2 mM EDTA, 1%
sodium deoxycholate, 100 mM sodium fluoride, 1% Triton X-
100 and protease-inhibitor cocktail. The homogenates were
transferred to 1.5 mL Eppendorf tubes and centrifuged at
13,000g for 20 minutes at 4C to remove debris and insol-
uble material. Aliquots of the supernatants were assayed
with Coomassie protein assay reagent to determine total
protein concentration and then stored at 80C until
further analysis.
Dimethyl labeling and peptide preparation
Volumes of lysates containing 100 mg of total proteins from
normal or varicose veins were adjusted to 60 mL and treated
with 0.7 mL of 1 M DTT and 9.3 mL of 7.5% SDS at 95C for 5
minutes before reduction. After the reaction, lysates were
further treated with 8 mL of 50 mM IAM at room temperature
for 30 minutes alkylation in the dark; the proteins were
precipitated by adding 52 mL of 50% TCA followed by incu-
bation on ice for 15minutes. After removing the supernatant
by centrifugation at 13,000g for 5 minutes, the collected
proteins were washed with 150 mL of 10% TCA, vortexed, and
centrifuged at 13,000g for 10 minutes. The precipitatedFigure 1. Schematic representation of the procedures used to a
analyses of proteomic changes in clinical samples of varicose vein ti
and nanoLC-MS/MS coupled with stable isotope dimethyl labeling.proteins were rewashed with 250 mL distilled H2O, vortexed
and centrifuged under the same condition three times. The
resulting pellets were then resuspended with 50 mM
NH4HCO3 (pH 8.5), digested with 4 mg of trypsin for 8 hours at
37C, and dried in a vacuum centrifuge to remove NH4HCO3.
Lyophilized peptides for normal and varicose vein samples
re-dissolved in 180 mL of 100 mM sodium acetate at pH 5.5
were then treated with 20 mL of 4% formaldehyde-H2 and
20 mL of 4% formaldehyde-D2, respectively [21,23], and
mixed thoroughly. Immediately after vortexing for 5 mi-
nutes, 20 mL of 3 M sodium cyanoborohydride were added
vortexed for 1 hour at room temperature. The resultant liq-
uids were acidified by 10% TFA/H2O to pH 2.0e3.0 and
applied onto the reverse phase C18 column pre-equilibrated
with 200 mL of 0.1% TFA/H2O (pH 2.0e3.0). The column was
also washed with 200 mL of 0.1% TFA/H2O (pH 3.0) and then
elutedwith a stepwise ACN gradient from 50% to 100% in 0.1%
TFA at room temperature.
Hydrophilic interaction chromatography for
peptide separation
Hydrophilic interaction chromatography (HILIC) was per-
formed on an L-7100 pump system with quaternary gradient
capability (Hitachi, Tokyo, Japan) using a TSK gel Amide-80
HILIC column (2.0 mm  150 mm, 3 mm; Tosoh Biosciences,
Tokyo, Japan) [24e26] with a flow rate of 200 mL/minute.
Two buffers were used for gradient elution: solvent (A),
0.1% TFA in 100% ACN, and solvent (B), 0.1% TFA in water.
Each fraction eluted from the reverse-phase C18 column
was dissolved in 50 mL of solution containing 85% ACN and
0.1% TFA and then injected into the 100 mL sample loop.
The gradient was processed as follows: 0e2% (B) for 4 mi-
nutes; 2e8% (B) for 4 minutes; 8e12% (B) for 4 minutes;
12e35% (B) for 54 minutes; 35e100% (B) for 12 minutes; andnalyze and compare protein expression. Quantitative shotgun
ssues were performed by using HILIC-C18 for peptide separation
Quantitative proteomics analysis of varicose veins 597100% (B) for 2 minutes. Ten 1-mL fractions were collected
and dried in a vacuum centrifuge.
NanoLC-MS/MS analysis
The lyophilized powders were reconstituted in 10 mL of 0.1%
FA in H2O and analyzed by LTQ Orbitrap XL (Thermo Fisher
Scientific, San Jose, CA, USA). Reverse phase nano LC sepa-
ration was performed on an Agilent 1200 series nanoflow
system (Agilent Technologies, Santa Clara, CA, USA). A 10-mL
sample of collected fractions was loaded onto an Agilent
Zorbax XDB C18 precolumn (0.35 mm, 5 mm) and separated
with a C18 column (i.d., 75 mm  15-cm, 3 mm). The mobile
phases used were: (A) 0.1% FA and (B) 0.1% FA in 100% ACN. A
linear gradient from 5% to 95% of (B) was applied over a 70-
minute period at a flow rate of 300 nL/minute. The pep-
tides were analyzed in positive ion mode by applying a
voltage of 1.8 kV to the injection needle. The MS wasFigure 2. The MS/MS CID spectra and ratios of isotopic pair
VSHVSTGGGASLELLEGK for phosphoglycerate kinase 1 and (B) AEGSD
Peptide quantification ratios (D/H) for normal (hydrogen labeling
Mascot Distiller program using the average area of the first three iso
Mascot search data and quantification results from each fraction
different fractions or at different retention times and charge stateoperated in a data-dependentmode, inwhich one full scan in
the Orbitrap was performed at m/z 400e1600 and at a scan
rate of 30 ms/scan. Fragmentation was performed in CID
mode with a normalized collision energy of 35 V. A repeat
duration of 30 seconds was applied to exclude the samem/z
ions from the reselection for fragmentation. An in-house
software system (Xcalibur, version 2.0.7, Thermo-Finnigan
Inc., San Jose, CA, USA) was used to manage instrument
control, data acquisition, and data processing.
Protein database search and characterization
Peptides were identified by peak lists converted from the
nanoLC-MS/MS spectra by bioinformatic searching against
Homo sapiens taxonomy in the Swiss-Prot databases for
exact matches using the Mascot search program (http://
www.matrixscience.com) [27,28]. Parameters were set as
follows: mass tolerance, 10 parts/million for precursor ionss (quantification ratios) of the representative peptides (A)
VANAVLDGADCIMLSGETAK for pyruvate kinase isozymes M1/M2.
) and varicose veins (deuterium labeling) were calculated by
topic peaks across the elution profile. The program merged the
, and peptide ratios for the same sequences obtained from
s were combined.
Fig. 2. (continued).
598 C.-J. Kuo et al.and 0.8 Da for fragment ions; no missed cleavage sites for
trypsin; fixed modification, carbamidomethyl cysteine;
quantification, dimethylation; optional modification,
oxidized methionine and amidated asparagine/glutamine.
A peptide with a Mascot individual ion score higher than 20
was considered positively identified (p < 0.05).
The peptide quantification ratios (D/H) for normal
(hydrogen labeling) and varicose veins (deuterium labeling)
were then calculated using Mascot Distiller program (version
2.3; Matrix Science Ltd., London, UK) for the average area of
the first three isotopic peaks across the elution profile. For
each fraction, the program merged the Mascot search data
and the quantification results by combining peptide ratios
with the same sequences even if their fractions, retention
times, and charge states differed [21].
Construction of signaling pathways and network
analysis of protein interaction
Pathwaysandnetworksofprotein interactionand the involved
prospective mechanism of ATP synthesis and utilization were
derived using software (www.ingenuity.com) developed by
Ingenuity Pathways Analysis (IPA; Ingenuity Systems, RedwoodCity, CA, USA). Protein factors characterized by proteomic
analysis were analyzed for associations with mapping related
to canonical pathways deposited in the IPA library.
Results
NanoLC-MS/MS analysis of protein expression levels
The comparative proteomics analysis of varicose veins in
this study was performed by shotgun proteomic approach.
Fig. 1 shows the scheme used for sample processing and
separation and the subsequent workflow for trypsin diges-
tion, dimethyl labeling and shotgun analysis. Normal and
varicose veins were first homogenized and lysed for protein
extraction. Under identical conditions, 100-mg samples of
total lysates were subjected to trypsin digestion and
dimethyl labeling. Respective tryptic peptide samples were
mixed at a 1:1 (w/w) ratio and then enriched by the
reverse-phase C18 column. Since the enriched peptide
population was too complex for full detection and charac-
terization in a single LC-MS/MS run, the enriched peptides
were fractionated by HILIC based on polarity difference and
harvested into 10 fractions.
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search parameter used to identify the peptides was set to
allow for no missed cleavage. Most peptides were separated
from one or two adjacent HILIC fractions, and peptides
identified by the in-house software were accepted if their
individual ion scores were higher than 20, which is the
cutoff point used for lower-quality MS/MS spectra [29e31].
The differential protein expression levels of normal versus
varicose veins were profiled in the experiments and shown
as 455 protein species with a confident identification from a
single LC-MS/MS run.
Identification and quantification of differentially
expressed proteins
After the differentially expressed proteins had been
confidently identified by dimethyl labeling, enzymeFigure 3. The MS/MS CID spectra and ratios of isotopic pair
SSTGSPTSPLNAEK for myosin light chain kinase and (B) EAFSLFDK fo
(hydrogen labeling) and varicose veins (deuterium labeling) was ca
the first three isotopic peaks across the elution profile. The program
each fraction, and peptide ratios for the same sequences obtaine
charge states were combined.digestion and peptide mass fingerprinting, the peptide
quantification ratio (D/H) was obtained by Mascot Distiller
program using the average area of the first 3 isotopic peaks
across each elution profile [21,22,32]. Figs. 2 and 3 show
the peaks for representative peptides, including phos-
phoglycerate kinase 1, pyruvate kinase isozymes M1/M2,
myosin light chain kinase (MYLK) and calmodulin. Notably,
Fig. 2A shows the isotopic pairs (quantification ratios) of
nanoLC and MS/MS CID spectra, which confirms that the D4
and H4-labeled peptides (VSHVSTGGGASLELLEGK) derived
from phosphoglycerate kinase 1, which had m/z values of
903.01 (þ2) and 898.99 (þ2), respectively, and a D/H ratio
of 0.4, were eluted simultaneously (w47 minutes) in HILIC
fraction 2. The D4- and H4-labeled peptides (AEGSDVA-
NAVLDGADCIMLSGETAK) from pyruvate kinase isozymes
M1/M2, which had m/z values of 1275.61 (þ2) and 1279.64
(þ2), respectively, and a D/H ratio of 0.63, were eluteds (quantification ratios) of the representative (A) peptides
r calmodulin. The peptide quantification ratio (D/H) for normal
lculated by Mascot Distiller program using the average area of
merged the Mascot search data and quantification results from
d from different fractions or at different retention times and
Fig. 3. (continued).
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Fig. 2B shows the isotopic pairs (quantification ratios) of
nanoLC and MS/MS CID spectra. The quantitative ratios
showed that these two key enzymes, which generate ATP
in the glycolysis pathway, were downregulated in the
patients.
In contrast, the isotopic pairs of nano LC and MS/MS
CID spectra shown in Fig. 3A revealed that D4- and H4-
labeled peptides (SSTGSPTSPLNAEK) derived from MYLK
had m/z values of 716.37 (þ2) and 720.40 (þ2), respec-
tively, and a D/H ratio of 0.76, were eluted simulta-
neously (w37 minutes) in the HILIC fraction 4. Fig. 3B
showed that the isotopic pairs (quantification ratios) of
nano LC and MS/MS CID spectra of D4 - and H4-labeled
peptides (EAFSLFDK) from calmodulin, which had m/z
values of 506.77 (þ2) and 510.80 (þ2), respectively, and a
D/H ratio of 0.35, were eluted simultaneously (w56minutes) in HILIC fraction 3. That is, the patients showed
downregulation of two proteins that mediate ATP utili-
zation in smooth muscle contraction. The above results
further confirmed the absence of an isotopic effect in the
two-dimensional HILIC-C18 separation and excellent effi-
ciency in separating dimethylated peptides fractionated
by HILIC column. It was hypothesized that the improved
efficiency resulted mainly from the high orthogonality of
HILIC and the reverse-phase C18 column.
By using the Mascot Distiller program, data from the
Mascot search engine and the quantification results for
each fraction were merged into one file in which peptides
were combined if more than one peptide had matching
sequences (i.e., if they had been harvested from
different fractions, at different retention times, or in
different charge states). Twelve proteins showed highly
consistent downregulation of protein expression, which
Quantitative proteomics analysis of varicose veins 601signifies that this downregulatory effect may be universal
in these patients. All 12 identified proteins were directly
or indirectly involved in energy generation and utiliza-
tion. Eight were glycolysis-related proteins: glucose-6-
phosphate isomerase, phosphoglycerate mutase 1,
fructose-bisphosphate aldolase A, phosphoglycerate ki-
nase 1, pyruvate kinase isozymes M1/M2, triosephosphate
isomerase, a-enolase, and anaerobic glycolysis enzyme
identified as lactate dehydrogenase B chain. Two pro-
teins, calmodulin and MYLK, showed associations with
ATP utilization and regulation. The remaining two pro-
teins, mitochondrial ATP synthase b subunit and creatine
kinase B type, are known to participate in ATP generation
and function as energy reservoirs. Table 1 lists their
sequence coverage and match scores. The amino acid
sequence coverage of the identified proteins varied from
13% to 50%. For example, phosphoglycerate kinase 1 had
42% sequence coverage based on 33 matched peptides;
pyruvate kinase isozymes M1/M2 showed 65% sequence
coverage based on 39 matched peptides, and fructose-
bisphosphate aldolase A showed 50% sequence coverage
based on 69 matched peptides.
Although the shotgun proteomic analysis revealed
differential expression in 455 proteins, few of the up- or
down-regulated protein species that showed associations
with cytoskeletal assembly, extracellular matrix forma-
tion, enzyme catalysis or inflammation in this quantita-
tive analysis showed clear up- or down-regulation among
the patients. Therefore, protein factors involved in ATP
utilization and regulation were selected for further
analysis.Table 1 Proteins in patients with varicose veins showing downr
spectrometry.
Number Protein ID Swiss-Prot
accession
number
Sco
Energy reservoir
1 Creatine kinase B-type P12277 3
Energy generation
Glycolysis
2 Glucose-6-phosphate isomerase P06744 1
3 Phosphoglycerate mutase 1 P18669 6
4 Fructose-bisphosphate aldolase A P04075 2
5 Phosphoglycerate kinase 1 P00558 9
6 Pyruvate kinase isozymes M1/M2 P14618 3
7 Triose phosphate isomerase P60174 4
8 a-enolase P06733 7
Respiration and fermentation
9 Mitochondrial ATP synthase b
subunit
P06576 1
Anaerobic glycolysis
10 L-Lactate dehydrogenase B chain P07195 4
Energy utilization
11 Calmodulin P62158 7
12 Myosin light chain kinase Q15746 1
Protein expression ratios of D/H shown here are the mean  standar
D Z deuterium labeling (varicose veins); H Z hydrogen labeling (norConstruction of signaling pathways and network
analysis of protein interaction
Fig. 4 shows the results obtained by using IPA software for
further analysis of the metabolic pathways and key enzymes
or proteins that showed associations with ATP utilization and
generation. Calcium from the sarcoplasmic reticulum and
extracellular spaces is a major regulator of venous smooth
muscle function. As it enters the cytosol, it associates with
calmodulin to form a complex. The complex then activates
MYLK, which uses ATP to promote myosin phosphorylation.
By interacting with actin, phosphorylated myosin then
upregulates contractile activity in vascular smooth muscle.
The results of the above experiment suggest that varicose
vein formation may result from attenuation of this contrac-
tile force by downregulation of key enzymes that mediate
ATP synthesis and utilization.Discussion
Biochemical and histological studies show that varicose
veins result from incoordination and dysfunction in meta-
bolic pathways and from dysfunctional regulation of
expression in many proteins [4,15,33e36]. Morphological
evidence generally agree with the fact that structural
remodeling characterized by accumulation of collagen,
proteoglycans, and elastic fibers in smooth muscle cells
decreases elasticity of the veins while concomitantly
causing inflammation and thrombus [16,17]. However, the
conventional phenotype characterization is insufficient foregulation identified by nano liquid chromatography and mass
re/match pI/mass,
kDa
Sequence
coverage %
Protein expression
ratio (D/H)
683/53 5.34/42.64 48 0.32  0.197
84/8 8.42/63.15 18 0.45  0.130
24/16 6.67/28.80 25 0.44  0.068
946/69 8.30/39.42 50 0.52  0.107
51/33 8.30/44.61 42 0.5  0.077
147/65 7.96/57.94 39 0.55  0.106
452/49 5.65/30.79 50 0.61  0.139
624/71 7.01/47.17 43 0.61  0.071
07/6 5.26/56.56 15 0.79  0.154
42/18 5.71/36.64 22 0.64  0.059
77/13 4.09/16.84 36 0.37  0.235
168/23 5.85/210.72 13 0.61  0.320
d deviation of triplicate measurements.
mal veins).
Figure 4. Schematic representation of derived pathways associated with ATP synthesis and utilization. The networks of these
identified proteins mapped to canonical pathways from the Ingenuity Pathways Analysis (Ingenuity Systems) library were used to
compare significantly downregulated protein molecules between normal and diseased tissues. Identified proteins are displayed in
red and have different shapes to indicate different functions associated with these molecules, including ATP-generating, ATP-
utilizing, and glycolytic enzymatic functions. The blue arrows indicate the biological interrelationships between molecules. All
arrows in the figure were supported by at least one reference from the literature, textbooks, or canonical information stored in the
Ingenuity Knowledge Base. As the development of varicose veins progresses, systematic decreases in these enzymes may cause
dysfunctions in vascular smooth muscle followed by morphological aberrations.
602 C.-J. Kuo et al.a functional study of factors related to contractile or
relaxing machinery. Venous contraction and relaxation
have a well-known dependency on the functional interac-
tion of actin, myosin, and other coordinating components in
vascular smooth muscle [37e39]. Thus, abnormal vasodi-
lation may result from the reduction or loss of contractile
force in smooth muscle cells.
Since the causes of abnormal vasodilation in veins have
not been adequately studied and are poorly understood,
the aim of this study was to perform a quantitative prote-
omic analysis to elucidate the protein expression profile
and the related pathogenesis of altered vascular contrac-
tility in varicose veins. The analysis showed that patients
diagnosed with varicose veins had dramatically lower levelsof ATP yield, ATP utilization, and glycolytic enzymes
compared to normal controls based on the obtained D/H
quantification ratios ranging from 0.32 (creatine kinase B-
type) to 0.79 (ATP synthase b subunit; Table 1). The
metabolic disorder resulting from decreased enzyme
expression may be highly unfavorable to the mediating and
regulatory functions of vascular smooth muscle in vasodi-
lation or vasoconstriction.
As in all other cells, smooth muscle cells regenerate ATP
through three metabolic pathways: oxidative phosphoryla-
tion, creatine kinase catalysis, and glycolysis. Among the
involved enzymes, a marked decrease in the expression of
B-type creatine kinase, which is known to convert phos-
phate groups from phosphocreatine to ADP, was followed by
Quantitative proteomics analysis of varicose veins 603formation of ATP and the nitrogenous substance creatine.
This showed that, by serving as an intermediate storage
pool, phosphocreatine enables instantaneous availability of
almost any high-energy phosphate [40]. In the mitochon-
drial environment, the b subunit of ATP synthase from
which ATP is actually generated also revealed down-
regulation, which suggests that impairment of its enzymatic
function by the proton gradient generated by oxidative
phosphorylation may reduce ATP levels in venous tissue.
Phosphoglycerate kinase 1 and pyruvate kinase isozymes
M1/M2 are key enzymes for energy release because their
catalytic activities initiate phosphate-group transfer re-
actions. By transferring a phosphate group from 1,3-
bisphosphoglycerate to ADP, phosphoglycerate kinase 1
yields ATP and 3-phosphoglycerate [41,42] whereas pyru-
vate kinase isozymes M1/M2 can catalyze the transfer of a
phosphate group from phosphoenolpyruvate (PEP) to ADP,
which generates one pyruvate molecule and one ATP
molecule [43]. Phosphoglycerate kinase 1 and pyruvate ki-
nase isozymes M1/M2 had D/H quantification ratios of 0.4
and 0.63, respectively (Fig. 2), which signifies a decreased
ATP yield in the varicose vein tissues.
In addition to defects in ATP synthesis and supply,
impeded mobilization of cellular components involved in
the transformation of chemical energy from ATP to me-
chanical energy impeded actinemyosin interaction in
smooth muscle. As in the skeletal muscle, contraction of
smooth muscle in the vein vessel requires calcium ions and
ATP. Calcium transported into the cytosol associates with
calmodulin, a protein functionally similar to troponin in
skeletal muscle [44]. The calmodulin-calcium complex can
then activate MYLK, which then further catalyzes the
binding of a high-energy phosphate to myosin. Myosin in-
teracts with actin only after MYLK phosphorylation causes
muscle contraction [45e49]. The observed D/H quantifica-
tion ratios of 0.61 for MYLK (Fig. 3A) and 0.37 for calmod-
ulin (Fig. 3B), suggest that ATP utilization of veins remained
attenuated.
A continuous supply of large quantities of ATP from
metabolic processes of muscle is needed to maintain
contraction machinery, energy storage and calcium trans-
port. Inhibition of the glycolysis pathway and down-
regulation of ATP utilization not only attenuate various
physiological processes, but also attenuate the energy
supply needed for physical activity. This study focused on
12 protein factors related to ATP generation and utilization
since other protein species known to be associated with
cytoskeletal assembly or cellular morphology showed no
clear up- or down-regulation among these patients. The
availability of low levels of both ATP-generating and ATP-
utilizing enzymes may thus partly explain dysfunction of
the smooth muscle lining of the vein vessel followed by
progressively worsening morphological aberrations in vari-
cose veins (Fig. 4).
This study used stable isotope dimethyl labeling coupled
with nanoLC-MS/MS for quantitative shotgun analysis of
proteomic changes in clinical samples of varicose vein tis-
sues by LTQ Orbitrap mass spectrometer. In terms of
sensitivity and efficiency of proteomic analysis of complex
biological tissues, this approach is superior to presample
protein fractionation based on 2D-gel electrophoresis fol-
lowed by LC-tandem MS analysis.Conclusion
This report, which is the first characterization and
description of energy-oriented enzyme synthesis in vari-
cose veins, corroborates the supposition that primary
weakness of the vein wall may have a major role in the
pathogenesis of varicosity of venous vessels [14,50]. This
study provides novel insights into the biochemical mecha-
nisms of this disease and provides a basis for further studies
needed to validate, evaluate, and clinically translate bio-
markers into targeted therapies for this disease. Collec-
tively, the severity of varicose veins involves various
protein factors that have regulatory roles in metabolic
coordination of physiological functions. Further studies are
needed to explore other factors such as collagens [51]
associated with maintenance of vascular morphology and
contractility for improved understanding of the mecha-
nisms underlying vein remodeling and the corresponding
formation of varicose veins under specific physiological
conditions.
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